The serum IL-6, IL-1β, and TNF-α expression levels were measured by RT-PCR in COVID-19 patients (n = 41), stratified into non-survivors (n = 23) and survivors (n = 18), and in the serum of subjects in the control group (n = 20). This evidence concerns the gene IL6 and COVID-19.